Bonk (NASDAQ:BNKK) Announces Quarterly Earnings Results

Bonk (NASDAQ:BNKK) released its quarterly earnings results on Wednesday. The company reported ($0.23) EPS for the quarter, FiscalAI reports. Bonk had a negative net margin of 1,993.19% and a negative return on equity of 208.29%. The business had revenue of $0.79 million during the quarter.

Bonk Trading Down 2.2%

BNKK stock traded down $0.05 on Wednesday, hitting $2.20. The company’s stock had a trading volume of 145,911 shares, compared to its average volume of 955,631. The stock has a market capitalization of $17.31 million, a PE ratio of -0.29 and a beta of 1.97. The firm’s 50 day simple moving average is $2.71. Bonk has a 1 year low of $2.15 and a 1 year high of $46.90.

Insider Transactions at Bonk

In other news, Director Mitchell Austin Rudy acquired 31,055 shares of the company’s stock in a transaction on Thursday, April 9th. The shares were bought at an average cost of $2.82 per share, with a total value of $87,575.10. Following the purchase, the director owned 44,198 shares of the company’s stock, valued at $124,638.36. This represents a 236.29% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 51.60% of the company’s stock.

Hedge Funds Weigh In On Bonk

Several institutional investors have recently bought and sold shares of the company. State Street Corp acquired a new position in Bonk in the 4th quarter valued at $33,000. Steward Partners Investment Advisory LLC acquired a new position in Bonk in the 4th quarter valued at $37,000. Jane Street Group LLC acquired a new position in Bonk in the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk in the 4th quarter valued at $128,000. 12.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Bonk currently has an average rating of “Sell”.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.